# EDGAR Filing Document

**Accession Number:** 0002079272
**File Stem:** 0000000000-26-004726
**Filing Date:** 2026-5
**Character Count:** 2262
**Document Hash:** 790f9c18faf14e76cc40fa5d6afd75d2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-004726.hdr.sgml**: 20260616

**ACCESSION NUMBER**: 0000000000-26-004726

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260508

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lakewood-Amedex Biotherapeutics Inc.
- **CENTRAL INDEX KEY:** 0002079272
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 205274304
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-295497

**BUSINESS ADDRESS:**
- **STREET 1:** 8031 COOPER CREEK BLVD.
- **STREET 2:** SUITE 103
- **CITY:** UNIVERSITY PARK
- **STATE:** FL
- **ZIP:** 34201
- **BUSINESS PHONE:** 9412252515

**MAIL ADDRESS:**
- **STREET 1:** 8031 COOPER CREEK BLVD.
- **STREET 2:** SUITE 103
- **CITY:** UNIVERSITY PARK
- **STATE:** FL
- **ZIP:** 34201
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-26-050936

## Text-Extract

```

                                                            May 8, 2026

Kelvin Cooper
Chief Executive Officer
Lakewood-Amedex Biotherapeutics Inc.
8031 Cooper Creek Blvd., Unit 103
University Park, Fl 34201

        Re: Lakewood-Amedex Biotherapeutics Inc.
            Registration Statement on Form S-1
            Filed May 01, 2026
            File No. 333-295497
Dear Kelvin Cooper:
       This is to advise you that we have not reviewed and will not review your
registration
statement.
       Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you that
the company and its management are responsible for the accuracy and adequacy of
their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.
       Please contact Doris Stacey Gama at 202-551-3188 with any questions.

                                                            Sincerely,

                                                            Division of
Corporation Finance
                                                            Office of Life
Sciences
cc:    Scott Linsky, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._